606 - Radium-223 re-treatment in patients with castration-resistant prostate cancer and bone metastases: 2-year follow-up from an international, open-label, phase 1/2 study

Autor: Heinrich, D., Nordquist, L., Mariados, N., Méndez Vidal, M.J., Keizman, D., Thellenberg Karlsson, C., Peer, A., Procopio, G., Frank, S., Pulkkanen, K., Rosenbaum, E., Severi, S., Trigo Perez, J.M., Trandafir, L., Wagner, V., Li, R., Sartor, O.
Zdroj: In European Urology Supplements March 2018 17(2):e872-e873
Databáze: ScienceDirect